Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Validation of Home Sleep Testing (WP200) Compared to an Overnight Sleep Testing in the Sleep Laboratory

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2014 by Itamar-Medical, Israel.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Itamar-Medical, Israel Identifier:
First received: March 28, 2012
Last updated: February 24, 2016
Last verified: April 2014
Obstructive sleep apnea syndrome (OSAS) is considered to be a major public health problem. The prevalence of OSAS is estimated at 2% and 4% for adult women and men respectively, most of whom are undiagnosed and untreated. The prevalence of snoring in children is high - 5% in the age group of 6 and less and about 1.5% above. The in-lab sleep study using full Polysomnography (PSG) and the manual scoring criteria set by the American Academy of Sleep Medicine was considered the gold standard for OSAS diagnosis. The high cost of in-lab full night PSG, together with long waiting lists for sleep studies, have led to the commonly used procedure of "split-night" for OSAS patients, as well as to the development of a variety of ambulatory sleep study systems. The primary study objective is to compare the efficacy of the WatchPAT200 (WP200), as an ambulatory device for aiding in the diagnosis of sleep disorders for subjects from age 5 to 90, to the manual scoring of the PSG that serves as a "gold standard".

Sleep Disorders

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Validation of Home Sleep Testing (WP200) Compared to an Overnight Sleep Testing in the Sleep Laboratory

Resource links provided by NLM:

Further study details as provided by Itamar-Medical, Israel:

Primary Outcome Measures:
  • Compare sleep data collected from the Watch-PAT200 device to PSG data [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: July 2012
Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   5 Years to 90 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adults and children with and without sleep disorders, referred to Carmel Medical Center clinical sleep laboratory for an overnight sleep study

Inclusion Criteria:

  1. Age between 5-90
  2. Subjects that are able to read understand and sign the informed consent form to undergo an overnight sleep study in the clinical sleep laboratory

Exclusion Criteria:

  1. Permanent pacemaker.
  2. Severe lung disease.
  3. Peripheral neuropathy.
  4. Finger deformity that precludes adequate sensor appliance.
  5. Using one of the following medications: short/Long acting nitrates (less than 3 hours before the sleep study) or alpha-adrenergic receptor blockers (less than 24 hours before the sleep study).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01570738

Carmel Medical Center Recruiting
Haifa, Israel
Contact: Giora Pillar   
Principal Investigator: Giora Pillar, Prof.         
Sponsors and Collaborators
Itamar-Medical, Israel
  More Information

Responsible Party: Itamar-Medical, Israel Identifier: NCT01570738     History of Changes
Other Study ID Numbers: Carmel-001 
Study First Received: March 28, 2012
Last Updated: February 24, 2016
Health Authority: Israel: Ethics Commission

Keywords provided by Itamar-Medical, Israel:
sleep disorders
sleep apnea
ambulatory device

Additional relevant MeSH terms:
Sleep Wake Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders processed this record on October 25, 2016